After 67 years old, Anil Vij Haryana’s Health Minister tested positive for COVID-19 two weeks after being administered to COVID-19 vaccine. Bharat Biotech released a statement for clarification.
As reported by CNBC, Bharat Biotech who is developing the vaccine, said the clinical trials of Covaxin are based on a two-dose schedule, given 28 days apart. “The vaccine efficacy will be determined 14 days post the second dose. Covaxin has been designed to be efficacious when subjects receive both doses,” the drugmaker said, reacting to the news of the Haryana minister testing positive.
Anil Vij who is also Haryana’s Health Minister announced on November 20 that he was administered a trial dose of a COVID-19 vaccine as part of the third phase trial of Bharat Biotech’s Covaxin. He had earlier reached out on Twitter saying that he will be the first volunteer in his state for the anti-COVID-19 vaccine.
Covaxin has been evaluated in about 1,000 subjects in the first two phases of clinical trials, with promising safety and immunogenicity data.
“The Phase-3 trials are double-blinded and randomised, where 50% of subjects (participants in the trial) receive the vaccine and 50% of subjects receive placebo,” the company said.
Haryana has reported over 2.4 lakh COVID-19 cases so far, including 2,539 deaths.
